
Met PG 1mg/500mg/15mg Tablet SR
Marketer
Elis Pharmaceuticals India Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Met PG 1mg/500mg/15mg Tablet SR
Met PG 1mg/500mg/15mg Extended-Release tablets are a triple-combination medication designed to manage blood glucose. This medication, used alongside diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It facilitates improved insulin utilization, consequently reducing blood sugar. Adhere strictly to your physician's prescribed dosage and regimen for Met PG 1mg/500mg/15mg Extended-Release tablets. Administer this medication with food to mitigate potential gastrointestinal discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume your regular schedule. Never double the dose. An overdose can trigger hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is essential. Common adverse reactions may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should also seek medical counsel before use. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption while taking this medication to minimize the risk of side effects.
Uses of Met PG 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Met PG 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Met PG 1mg/500mg/15mg Extended-Release tablet should be taken with food.
Common Side effects of Met PG 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Met PG 1mg/500mg/15mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or fracture it. Consume the Met PG 1mg/500mg/15mg extended-release tablet with a meal.
How Met PG 1mg/500mg/15mg Tablet SR works:
Met PG 1mg/500mg/15mg Extended-Release tablets contain glimepiride, metformin, and pioglitazone, three antidiabetic agents with complementary actions. This triple combination improves blood sugar management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. Pioglitazone, a thiazolidinedione, further boosts insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol consumption and Met PG 1mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Met PG 1mg/500mg/15mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Met PG 1mg/500mg/15mg tablets are likely not safe for breastfeeding mothers. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.
KidneyCAUTION
Patients with kidney impairment should use Met PG 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician. This medication is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Met PG 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Met PG 1mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Met PG 1mg/500mg/15mg Tablet SR :
Should you forget to take a Met PG 1mg/500mg/15mg SR tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Met PG 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
